Infliximab
- Level
- Commodity
- Parent
- 51202400
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51202409This classification denotes a monoclonal antibody with the molecular formula C6428H9912N1694O1987S46, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) B72HH48FLU, more generally known as infliximab. European Medicines Agency schedules infliximab in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02681MIG. The term INFLIXIMAB is an International Non-Proprietary Name or INN. see WHO INN reference publication, Volume 12 no. 1 1998, list 39. Most nations, for tariff and trade purposes, schedule infliximab under HS 30021091 and SITC 54163. As of Q4 2014, INFLIXIMAB remains US FDA's Preferred Term for this commodity. Infliximab bears US NLM identifiers UMLS ID C0666743 and NCI Concept Code C1789. SMILES: none.
Same parent
Under 51202400 · 21Activities that produce or sell this
KBLI · 8Inherited from family 51200000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.